Talc
CAS 14807-96-6
Talc (CAS 14807-96-6) is a pharmaceutical compound with 0 bioactivity targets and 13 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| Talc | 10323 | SU | MTHSPL |
| TALC | 10323 | SU | MTHSPL |
| talc | 10323 | SU | MTHSPL |
| talc | 10323 | IN | RXNORM |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Talc used for in pharmaceutical contexts?
Talc (CAS 14807-96-6) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Talc?
Talc has 13 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Breast cancer, Diverticulitis, Epithelioid mesothelioma, Exposure to chemical pollution, Lung squamous cell carcinoma metastatic. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Talc also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Talc with EU status "permitted".
What clinical phase is Talc in?
No phase 1-4 clinical development badge is rendered for Talc because the matched compound identifier rows do not contain a max-phase value.